Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

283 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.
Duffy MJ, Maguire TM, McDermott EW, O'Higgins N. Duffy MJ, et al. J Surg Oncol. 1999 Jun;71(2):130-5. doi: 10.1002/(sici)1096-9098(199906)71:2<130::aid-jso14>;2-9. J Surg Oncol. 1999. PMID: 10389872 Review.
Measurement of erbB-2 oncoprotein in human breast cancers by ELISA.
Nugent A, McDermott E, O'Higgins N, Fennelly JJ, Duffy MJ. Nugent A, et al. Among authors: duffy mj. Biochem Soc Trans. 1992 Feb;20(1):82S. doi: 10.1042/bst020082s. Biochem Soc Trans. 1992. PMID: 1353039 No abstract available.
Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer.
Nugent A, McDermott E, Duffy K, O'Higgins N, Fennelly JJ, Duffy MJ. Nugent A, et al. Among authors: duffy k, duffy mj. Clin Chem. 1992 Aug;38(8 Pt 1):1471-4. Clin Chem. 1992. PMID: 1353709
Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival.
Duffy MJ, Reilly D, Brouillet JP, McDermott EW, Faul C, O'Higgins N, Fennelly JJ, Maudelonde T, Rochefort H. Duffy MJ, et al. Clin Chem. 1992 Oct;38(10):2114-6. Clin Chem. 1992. PMID: 1395002
CA 15-3 in patients with locoregional and metastatic breast carcinoma.
Geraghty JG, Coveney EC, Sherry F, O'Higgins NJ, Duffy MJ. Geraghty JG, et al. Among authors: duffy mj. Cancer. 1992 Dec 15;70(12):2831-4. doi: 10.1002/1097-0142(19921215)70:12<2831::aid-cncr2820701218>;2-8. Cancer. 1992. PMID: 1451063
Inhibiting tissue invasion and metastasis as targets for cancer therapy.
Duffy MJ. Duffy MJ. Biotherapy. 1992;4(1):45-52. doi: 10.1007/BF02171709. Biotherapy. 1992. PMID: 1543650 Review.
The role of proteolytic enzymes in cancer invasion and metastasis.
Duffy MJ. Duffy MJ. Clin Exp Metastasis. 1992 May;10(3):145-55. doi: 10.1007/BF00132746. Clin Exp Metastasis. 1992. PMID: 1582084 Review.
Plasminogen activator inhibitor type 1 and 2 in human breast cancer.
Reilly DM, Andreasen PA, Duch M, Nolan N, Lecander I, Duffy MJ. Reilly DM, et al. Among authors: duffy mj. Biochem Soc Trans. 1992 Feb;20(1):88S. doi: 10.1042/bst020088s. Biochem Soc Trans. 1992. PMID: 1634010 No abstract available.
Type-1 plasminogen activator inhibitor in human breast carcinomas.
Reilly D, Christensen L, Duch M, Nolan N, Duffy MJ, Andreasen PA. Reilly D, et al. Among authors: duffy mj. Int J Cancer. 1992 Jan 21;50(2):208-14. doi: 10.1002/ijc.2910500209. Int J Cancer. 1992. PMID: 1730515
Urokinase-plasminogen activator in breast cancer: assay by both catalytic and immunoassay.
Reilly D, Andreasen PA, Duffy MJ. Reilly D, et al. Among authors: duffy mj. Blood Coagul Fibrinolysis. 1991 Feb;2(1):47-50. Blood Coagul Fibrinolysis. 1991. PMID: 1772998
283 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page